Literature DB >> 19644765

Lack of apoE causes alteration of cytokines expression in young mice liver.

Miao Yin1, Liang Zhang, Xiao-ming Sun, Liu-feng Mao, Jie Pan.   

Abstract

To investigate the effect of apolipoprotein E (apoE) on cytokine expression profile of the liver of young mice, quantitative RT-PCR (qRT-PCR) assay and cytokine antibody array for multiplex analysis of 62 cytokines have been used to analyze characteristics of expression of cytokines in the liver of 6-week-old apoE-null (apoE(-/-)) mice. The levels of plasma cytokines were also analyzed. The mRNA level of IL-1 beta, IL-2, IL-6, ICAM-1, VCAM-1, MCP-1, NF-kappaB (p65), IFN-gamma and I kappaB-alpha were increased significantly in apoE(-/-) mice comparative to wild-type (WT) mice. IL-4, IL-10 and GM-CSF, however, were slightly decreased. Compared with WT, levels of 21 cytokines altered twofold or more in apoE(-/-) mice, including 10 cytokines increased and 11 decreased. Expression patterns of IL-1 beta, IL-2, IL-4, IL-6, IL-10, GM-CSF, IFN-gamma and VCAM-1 showed identical trend between cytokine antibody array and qRT-PCR analysis. Moreover, levels of IL-1 beta, IFN-gamma and IL-6 in the plasma were elevated, while IL-4 was lightly decreased in apoE(-/-) mice compared to those in WT mice. These results implied that promotion of type I immune response in the liver of young apoE(-/-) mice due to alteration of these cytokines, and the phenotypes may be caused by the regulation of NF-kappaB. The inflammation and lipid metabolism dysfunction in the liver cooperated in dysfunction of the liver in young apoE(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644765     DOI: 10.1007/s11033-009-9660-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  17 in total

1.  CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.

Authors:  Michael Lehrke; Segan C Millington; Martina Lefterova; Reshmaal Gomes Cumaranatunge; Philippe Szapary; Robert Wilensky; Daniel J Rader; Mitchell A Lazar; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2007-01-12       Impact factor: 24.094

2.  GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice.

Authors:  Michael Ditiatkovski; Ban-Hock Toh; Alex Bobik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-07-27       Impact factor: 8.311

3.  Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae.

Authors:  N de Bont; M G Netea; P N Demacker; B J Kullberg; J W van der Meer; A F Stalenhoef
Journal:  Eur J Clin Invest       Date:  2000-09       Impact factor: 4.686

4.  Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.

Authors:  M G Pepe; L K Curtiss
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

5.  Apolipoprotein E suppresses the type I inflammatory response in vivo.

Authors:  Kamilah Ali; Melissa Middleton; Ellen Puré; Daniel J Rader
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

6.  Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Amir Haghighat; Daiana Weiss; Matthew K Whalin; D Patrick Cowan; W Robert Taylor
Journal:  Circulation       Date:  2007-04-02       Impact factor: 29.690

7.  Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

Authors:  C Y Fan; J Pan; N Usuda; A V Yeldandi; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

8.  [Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice].

Authors:  Hong-Yan Ye; Miao Yin; Yun-Ju Shang; Xue-Dong Dai; Sheng-Qiang Zhang; Wen Jing; Hui-Qin Du; Liang Zhang; Jie Pan
Journal:  Sheng Li Xue Bao       Date:  2008-02-25

9.  Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

Authors:  M E Kelly; M A Clay; M J Mistry; H M Hsieh-Li; J A Harmony
Journal:  Cell Immunol       Date:  1994-12       Impact factor: 4.868

10.  Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice.

Authors:  Ning Xiao; Miao Yin; Liang Zhang; Xuebin Qu; Hui Du; Xiaoming Sun; Liufeng Mao; Guocheng Ren; Cong Zhang; Yue Geng; Liguo An; Jie Pan
Journal:  Mol Genet Metab       Date:  2009-01-20       Impact factor: 4.797

View more
  14 in total

1.  H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.

Authors:  Vineesh V Raveendran; Karen M Kassel; Donald D Smith; James P Luyendyk; Kurt J Williams; Rachel Cherian; Gregory A Reed; Colleen A Flynn; Iván L Csanaky; Andrew L Lickteig; Matthew J Pratt-Hyatt; Curtis D Klaassen; Kottarappat N Dileepan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

2.  Genetic association of apolipoprotein E polymorphisms with inflammatory bowel disease.

Authors:  Ebtissam Saleh Al-Meghaiseeb; Mulfi Mubarak Al-Otaibi; Abdulrahman Al-Robayan; Reem Al-Amro; Ahmd Saad Al-Malki; Misbahul Arfin; Abdulrahman K Al-Asmari
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  Hyperlipidemia Alters Regulatory T Cell Function and Promotes Resistance to Tolerance Induction Through Costimulatory Molecule Blockade.

Authors:  J Bagley; J Yuan; A Chandrakar; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

4.  Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.

Authors:  Alexis Broisat; Sophie Hernot; Jakub Toczek; Jens De Vos; Laurent M Riou; Sandrine Martin; Mitra Ahmadi; Nicole Thielens; Ulrich Wernery; Vicky Caveliers; Serge Muyldermans; Tony Lahoutte; Daniel Fagret; Catherine Ghezzi; Nick Devoogdt
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

5.  Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D.

Authors:  Yu Zhang; Yi Cong; Shaohui Wang; Shicui Zhang
Journal:  Mol Biol Rep       Date:  2010-09-17       Impact factor: 2.316

6.  Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia).

Authors:  Nataša Vučinić; Igor Djan; Edita Stokić; Biljana Božin; Dragana Obreht; Karmen Stankov; Mihajla Djan
Journal:  Mol Biol Rep       Date:  2014-05-31       Impact factor: 2.316

7.  Hypothermia stimulates glioma stem spheres to spontaneously dedifferentiate adjacent non-stem glioma cells.

Authors:  Lei Shi; Xifeng Fei; Guan Sun; Zhimin Wang; Yi Wan; Yanjun Zeng; Jun Guo
Journal:  Cell Mol Neurobiol       Date:  2014-09-17       Impact factor: 5.046

Review 8.  Cross-talk between apolipoprotein E and cytokines.

Authors:  Hongliang Zhang; Li-Min Wu; Jiang Wu
Journal:  Mediators Inflamm       Date:  2011-06-28       Impact factor: 4.711

9.  Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways.

Authors:  Paolo Olgiati; Antonis M Politis; George N Papadimitriou; Diana De Ronchi; Alessandro Serretti
Journal:  Int J Alzheimers Dis       Date:  2011-12-10

10.  The positive correlations of apolipoprotein E with disease activity and related cytokines in systemic lupus erythematosus.

Authors:  Li-Jun Song; Wei-Wei Liu; Yu-Chen Fan; Feng Qiu; Qi-Lin Chen; Xing-Fu Li; Feng Ding
Journal:  Diagn Pathol       Date:  2013-10-21       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.